NZ505073A - Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases - Google Patents
Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseasesInfo
- Publication number
- NZ505073A NZ505073A NZ505073A NZ50507398A NZ505073A NZ 505073 A NZ505073 A NZ 505073A NZ 505073 A NZ505073 A NZ 505073A NZ 50507398 A NZ50507398 A NZ 50507398A NZ 505073 A NZ505073 A NZ 505073A
- Authority
- NZ
- New Zealand
- Prior art keywords
- micelles
- useful
- surfactant
- inflammatory
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9704833A SE9704833D0 (sv) | 1997-12-22 | 1997-12-22 | New formulation |
PCT/SE1998/002426 WO1999032089A1 (en) | 1997-12-22 | 1998-12-22 | Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ505073A true NZ505073A (en) | 2002-09-27 |
Family
ID=20409536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ505073A NZ505073A (en) | 1997-12-22 | 1998-12-22 | Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1043973A1 (no) |
JP (1) | JP2001526210A (no) |
KR (1) | KR20010024789A (no) |
CN (1) | CN1283106A (no) |
AR (1) | AR017220A1 (no) |
AU (1) | AU1993599A (no) |
BR (1) | BR9813811A (no) |
CA (1) | CA2315782A1 (no) |
EE (1) | EE200000388A (no) |
HU (1) | HUP0102365A3 (no) |
ID (1) | ID26945A (no) |
IL (1) | IL136880A0 (no) |
NO (1) | NO20003220L (no) |
NZ (1) | NZ505073A (no) |
PL (1) | PL341361A1 (no) |
SE (1) | SE9704833D0 (no) |
SK (1) | SK9532000A3 (no) |
TR (1) | TR200001977T2 (no) |
WO (1) | WO1999032089A1 (no) |
ZA (1) | ZA9811461B (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9902674D0 (sv) * | 1999-07-12 | 1999-07-12 | Astra Ab | New composition |
SE0000332D0 (sv) * | 2000-01-31 | 2000-01-31 | Astrazeneca Ab | New use |
US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
SE0100901D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | New composition |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
WO2005018607A1 (ja) * | 2003-08-20 | 2005-03-03 | Ajinomoto Co., Inc. | 溶解性を改善した医薬品製剤 |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
CN100579510C (zh) * | 2006-04-13 | 2010-01-13 | 新疆维吾尔自治区包虫病临床研究所 | 新型前体胶束制剂及其生产方法 |
US20090143343A1 (en) | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
JP2011503113A (ja) * | 2007-11-13 | 2011-01-27 | メリテイジ ファーマ,インク. | 胃腸炎の治療用組成物 |
WO2010029374A1 (en) * | 2008-09-12 | 2010-03-18 | Critical Pharmaceuticals Limited | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
CN101982168B (zh) * | 2010-11-02 | 2012-05-23 | 山东大学 | 一种槲皮素纳米胶束制剂及其制备方法 |
CN102793678B (zh) * | 2011-05-26 | 2017-06-30 | 邓世明 | 一种不含吐温的多烯紫杉醇注射剂的制备方法 |
DE102011108948A1 (de) * | 2011-07-29 | 2013-01-31 | Achim Göpferich | Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen |
JP5456802B2 (ja) * | 2012-01-23 | 2014-04-02 | 株式会社Cac | 細胞遊走促進剤及び創傷治療用の経皮吸収剤 |
WO2015008301A1 (en) * | 2013-07-17 | 2015-01-22 | Council Of Scientific & Industrial Research | Pharmaceutical composition for the treatment of diminution of bone tissue |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
KR102086316B1 (ko) * | 2019-09-09 | 2020-03-09 | 한국콜마주식회사 | 경피흡수성이 우수한 화장료 조성물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
US4994439A (en) * | 1989-01-19 | 1991-02-19 | California Biotechnology Inc. | Transmembrane formulations for drug administration |
AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
-
1997
- 1997-12-22 SE SE9704833A patent/SE9704833D0/xx unknown
-
1998
- 1998-12-14 ZA ZA9811461A patent/ZA9811461B/xx unknown
- 1998-12-17 AR ARP980106453A patent/AR017220A1/es not_active Application Discontinuation
- 1998-12-22 SK SK953-2000A patent/SK9532000A3/sk unknown
- 1998-12-22 EP EP98964662A patent/EP1043973A1/en not_active Withdrawn
- 1998-12-22 IL IL13688098A patent/IL136880A0/xx unknown
- 1998-12-22 PL PL98341361A patent/PL341361A1/xx unknown
- 1998-12-22 TR TR2000/01977T patent/TR200001977T2/xx unknown
- 1998-12-22 ID IDW20001131A patent/ID26945A/id unknown
- 1998-12-22 CA CA002315782A patent/CA2315782A1/en not_active Abandoned
- 1998-12-22 CN CN98812507A patent/CN1283106A/zh active Pending
- 1998-12-22 JP JP2000525082A patent/JP2001526210A/ja active Pending
- 1998-12-22 NZ NZ505073A patent/NZ505073A/xx unknown
- 1998-12-22 KR KR1020007006879A patent/KR20010024789A/ko not_active Application Discontinuation
- 1998-12-22 HU HU0102365A patent/HUP0102365A3/hu unknown
- 1998-12-22 AU AU19935/99A patent/AU1993599A/en not_active Abandoned
- 1998-12-22 BR BR9813811-1A patent/BR9813811A/pt not_active IP Right Cessation
- 1998-12-22 WO PCT/SE1998/002426 patent/WO1999032089A1/en not_active Application Discontinuation
- 1998-12-22 EE EEP200000388A patent/EE200000388A/xx unknown
-
2000
- 2000-06-21 NO NO20003220A patent/NO20003220L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20003220D0 (no) | 2000-06-21 |
PL341361A1 (en) | 2001-04-09 |
AR017220A1 (es) | 2001-08-22 |
ZA9811461B (en) | 1999-06-22 |
HUP0102365A3 (en) | 2002-01-28 |
SK9532000A3 (en) | 2000-11-07 |
IL136880A0 (en) | 2001-06-14 |
AU1993599A (en) | 1999-07-12 |
WO1999032089A1 (en) | 1999-07-01 |
CA2315782A1 (en) | 1999-07-01 |
ID26945A (id) | 2001-02-22 |
SE9704833D0 (sv) | 1997-12-22 |
BR9813811A (pt) | 2000-10-03 |
KR20010024789A (ko) | 2001-03-26 |
NO20003220L (no) | 2000-08-22 |
CN1283106A (zh) | 2001-02-07 |
HUP0102365A2 (hu) | 2001-11-28 |
JP2001526210A (ja) | 2001-12-18 |
TR200001977T2 (tr) | 2000-12-21 |
EE200000388A (et) | 2002-02-15 |
EP1043973A1 (en) | 2000-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ505073A (en) | Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases | |
GC0000107A (en) | Water - soluble pharmaceutical compositions in an ionic complex an the use thereof. | |
IT1271462B (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
TR200102110T2 (tr) | Astım için formoterol ve flütikazon propiyonat kombinasyonları. | |
CA2180816A1 (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
CA2392879A1 (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
ES2082723B1 (es) | Formulacion farmaceutica de fluoxetina en forma dispersable. | |
CA2274596A1 (en) | Compositions and methods for enhancing intestinal function | |
CA2362499A1 (en) | Combinations of formoterol and mometasone furoate for asthma | |
DE69905368D1 (en) | Oxydiertes thymosin beta 4 | |
BR0112962B1 (pt) | Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos | |
ZA200007299B (en) | Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol. | |
DK1095932T3 (da) | Phenoxyeddikesyrederivat og pharmaceutiske sammensætninger omfattende den samme | |
NZ298677A (en) | Hydroxamic acid derivatives, preparation and pharmaceutical compositions thereof | |
EE200000225A (et) | Arüüloksüalküüldialküülamiinid, nende valmistamismeetodid ja farmatseutiline kompositsioon | |
DE69919179D1 (de) | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen | |
DE69932510D1 (de) | Vaskularisierungsinhibitoren | |
CA2368574A1 (en) | Compositions for preventing and treating type i allergy | |
CA2325360A1 (en) | Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases | |
AU2001264044A1 (en) | 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof | |
EP0670166A3 (en) | Pharmaceutical compositions for oral administration. | |
HUP0203429A3 (en) | Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone, process for their preparation and pharmaceutical compositions containing them | |
IL153540A0 (en) | THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS | |
SE0001916D0 (sv) | Novel formulation | |
ITFI940009A0 (it) | Antagonisti delle tachichinine, loro preparazione e formulazioni farmaceutiche che li contengono. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) | ||
PSEA | Patent sealed |